Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Amortization - Intangibles came in at $225.0 million in Q2 2026, down 12.11% year-over-year from $256.0 million in Q2 2025, and down 6.64% quarter-over-quarter from $241.0 million in Q1 2026.
Analysis
Bausch Health Companies (BHC) Amortization - Intangibles (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Amortization - Intangibles across 18 years of filings, most recently posting $225.0 million for Q2 2026.
- In Q2 2026, Amortization - Intangibles fell 12.11% year-over-year to $225.0 million; the TTM figure through Jun 2026 stood at $955.0 million (down 8.61% YoY), while the FY2025 annual figure was $1.0 billion, down 7.06% from the prior year.
- Amortization - Intangibles came in at $225.0 million for Q2 2026 at Bausch Health Companies, down from $241.0 million in the prior quarter.
- In the past five years, Amortization - Intangibles ranged from a high of $313.0 million in Q4 2022 to a low of $225.0 million in Q2 2026.
- Average Amortization - Intangibles over 5 years is $268.7 million, with a median of $269.5 million recorded in 2023.
- Year-over-year, Amortization - Intangibles slipped 16.11% in 2022 and gained 8.3% in 2024.
- Over 5 years, Amortization - Intangibles stood at $313.0 million in 2022, then slipped by 9.9% to $282.0 million in 2023, then slipped by 8.16% to $259.0 million in 2024, then slipped by 8.88% to $236.0 million in 2025, then decreased by 4.66% to $225.0 million in 2026.
- Per Business Quant data, the three most recent Amortization - Intangibles figures were $225.0 million in Q2 2026, $241.0 million in Q1 2026, and $236.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.72 Bn | 39.07 Bn | 2.15 Bn |
| 2 | Viatris | 19.14 Bn | 18.26 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.89 Bn | 9.71 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.34 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 494.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 994.43 Mn | 704.31 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 399.34 Mn | 358.09 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.33 Mn | 178.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 225.00 Mn |
| Mar 31, 2026 | 241.00 Mn |
| Dec 31, 2025 | 236.00 Mn |
| Sep 30, 2025 | 253.00 Mn |
| Jun 30, 2025 | 256.00 Mn |
| Mar 31, 2025 | 256.00 Mn |
| Dec 31, 2024 | 259.00 Mn |
| Sep 30, 2024 | 274.00 Mn |
| Jun 30, 2024 | 270.00 Mn |
| Mar 31, 2024 | 274.00 Mn |
| Dec 31, 2023 | 282.00 Mn |
| Sep 30, 2023 | 253.00 Mn |
| Jun 30, 2023 | 269.00 Mn |
| Mar 31, 2023 | 273.00 Mn |
| Dec 31, 2022 | 313.00 Mn |
| Sep 30, 2022 | 290.00 Mn |
| Jun 30, 2022 | 302.00 Mn |
| Mar 31, 2022 | 310.00 Mn |
| Dec 31, 2021 | 320.00 Mn |
| Sep 30, 2021 | 338.00 Mn |